Know Cancer

or
forgot password
  • cancer clinical trials in new haven, CT

  • A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Pancreatic Cancer
    A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Breast Cancer
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    Yale University
    New Haven, Connecticut 06520
    Peripheral T-cell Lymphoma
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    Yale University
    New Haven, Connecticut 06520
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    New Haven, Connecticut 06510
    Malignant Glioma
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
    Yale University, Yale Cancer Center
    New Haven, Connecticut 06520
    Hormone-Sensitive Breast Cancer, Breast Cancer
    Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
    Yale University, Comprehensive Cancer Center
    New Haven, Connecticut 06520
    Bladder Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Atopic Dermatitis
    Assessment Tool for Older Patients With Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Yale University
    New Haven, Connecticut 06520
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Glioblastoma Multiforme
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Carcinoma, Non-Small-Cell Lung
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Breast Neoplasms
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Hepatic Veno-Occlusive Disease
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    High Risk Stage III Melanoma
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Dept Of Internal Med, Sect Of Pulmonary & Critical Care Med
    New Haven, Connecticut 06510
    Venous Thrombosis
    FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Gastroesophageal Cancer, Gastric Cancer
    Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Myeloma
    Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Endometrial Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Yale University, School of Medicine
    New Haven, Connecticut 06520
    Thyroid Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Ovarian Neoplasms
    HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Advanced Breast Cancer
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Yale University
    New Haven, Connecticut 06520
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer
    Yale Smilow Cancer Center
    New Haven, Connecticut 06519
    Breast Cancer
    A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer
    Yale University Comprehensive Cancer Center
    New Haven, Connecticut 06520
    Colorectal Neoplasms
    A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Yale University
    New Haven, Connecticut 06520
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)
    Yale-New Haven Hospital-Women's Center
    New Haven, Connecticut 06520-8063
    Polycystic Ovarian Syndrome, Vitamin D Deficiency
    Airway Epithelium Gene Expression: AEGIS II
    Yale Univeristy
    New Haven, Connecticut
    Lung Cancer
    Compromised Microcirculation in Women With Polycystic Ovary Syndrome
    John B. Pierce Laboratory
    New Haven, Connecticut 06520
    Polycystic Ovary Syndrome
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Yale University
    New Haven, Connecticut 06520
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Relapsed Lymphomas, Refractory Lymphomas
    Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
    Yale University School Medicine
    New Haven, Connecticut 06519
    Rheumatoid Arthritis
    The Impact of Active Nurse Participation on Adenoma Detection During Routine Colonoscopy
    Yale-New Haven Hospital
    New Haven, Connecticut 06504
    Adenoma
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Yale Cancer Center-Section of Medical Oncology
    New Haven, Connecticut 06520
    Peripheral T-cell Lymphoma
    Strategic Timing of Antiretroviral Treatment
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    HIV Infection
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    Yale University
    New Haven, Connecticut 06520
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Yale University
    New Haven, Connecticut 06520
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cancer
    Study of Kidney Tumors in Young Patients
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Sarcoma
    Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
    Yale University School of Medicine/Yale New Haven Hospital
    New Haven, Connecticut 06520
    Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Yale University
    New Haven, Connecticut 06520
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    Yale MS Research Center
    New Haven, Connecticut
    Multiple Sclerosis, Relapsing-Remitting
    Smoking Cessation Treatment for Head and Neck Cancer Patients
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Smoking Cessation
    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Solid Tumors, Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Yale University
    New Haven, Connecticut 06520
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Advanced Malignancies
    Study of Blood Samples From Newborns With Down Syndrome
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Yale University
    New Haven, Connecticut 06520
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
    Yale Dermatology Associates
    New HAven, Connecticut 06519
    Hemangioma
    Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Non-small Cell Lung Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Yale University
    New Haven, Connecticut 06520
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Yale University
    New Haven, Connecticut 06520
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Non-Hodgkin's Lymphoma
    LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
    1199.15.10028 Boehringer Ingelheim Investigational Site
    New Haven, Connecticut
    Ovarian Neoplasms, Peritoneal Neoplasms